Literature DB >> 19915615

Enhanced mRNA cap methylation increases cyclin D1 expression and promotes cell transformation.

V H Cowling1.   

Abstract

Cap-dependent mRNA translation requires the methylation of the mRNA guanosine cap by RNA guanine-7-methyltransferase (RNMT). mRNA cap methylation was recently described to be rate-limiting for a subset of mRNAs, and to be enhanced by expression of c-Myc and E2F1, although the biological significance of this finding was not investigated. Here, it is reported that increased RNMT expression enhances cellular mRNA cap methyltransferase activity, promotes mammary epithelial cell transformation and cooperates with H-RasV12 or c-Myc to promote fibroblast cell transformation. Cyclin D1 is a prominent oncogene in epithelial tumours. A significant fraction of Cyclin D1 mRNA was found to be unmethylated on the mRNA cap and thus dormant in mammary epithelial cells. Cyclin D1 expression was increased by enhanced mRNA cap methylation. In summary, this report shows that mRNA cap methylation is rate-limiting for expression of an oncogene and cell transformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915615      PMCID: PMC3393636          DOI: 10.1038/onc.2009.368

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line.

Authors:  James DiRenzo; Sabina Signoretti; Noriaki Nakamura; Ramon Rivera-Gonzalez; William Sellers; Massimo Loda; Myles Brown
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

Review 2.  What messenger RNA capping tells us about eukaryotic evolution.

Authors:  Stewart Shuman
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

3.  ONCOMINE: a cancer microarray database and integrated data-mining platform.

Authors:  Daniel R Rhodes; Jianjun Yu; K Shanker; Nandan Deshpande; Radhika Varambally; Debashis Ghosh; Terrence Barrette; Akhilesh Pandey; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

4.  Capping of eucaryotic mRNAs.

Authors:  A J Shatkin
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

Review 5.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

6.  Repression of cyclin D1: a novel function of MYC.

Authors:  A Philipp; A Schneider; I Väsrik; K Finke; Y Xiong; D Beach; K Alitalo; M Eilers
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

7.  Cap methyltransferase selective binding and methylation of GpppG-RNA are stimulated by importin-alpha.

Authors:  Y Wen; A J Shatkin
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

Review 8.  Aberrant mRNA translation in cancer pathogenesis: an old concept revisited comes finally of age.

Authors:  Pier Paolo Pandolfi
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

9.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.

Authors:  Hans-Guido Wendel; Elisa De Stanchina; Jordan S Fridman; Abba Malina; Sagarika Ray; Scott Kogan; Carlos Cordon-Cardo; Jerry Pelletier; Scott W Lowe
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

10.  Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors.

Authors:  M D Cole; V H Cowling
Journal:  Oncogene       Date:  2009-01-12       Impact factor: 9.867

View more
  31 in total

Review 1.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

2.  Quantitative DNA hypomethylation of ligand Jagged1 and receptor Notch1 signifies occurrence and progression of breast carcinoma.

Authors:  Yuwen Cao; Yixiao Li; Na Zhang; Jianming Hu; Liang Yin; Zemin Pan; Yucong Li; Xiaoming Du; Wenjie Zhang; Feng Li
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 3.  Discovering and Mapping the Modified Nucleotides That Comprise the Epitranscriptome of mRNA.

Authors:  Bastian Linder; Samie R Jaffrey
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-06-03       Impact factor: 10.005

Review 4.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

5.  MYC Mediates mRNA Cap Methylation of Canonical Wnt/β-Catenin Signaling Transcripts By Recruiting CDK7 and RNA Methyltransferase.

Authors:  Valeriya Posternak; Matthew H Ung; Chao Cheng; Michael D Cole
Journal:  Mol Cancer Res       Date:  2016-11-29       Impact factor: 5.852

6.  From canonical to modified nucleotides: balancing translation and metabolism.

Authors:  Federica Accornero; Robert L Ross; Juan D Alfonzo
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-09-16       Impact factor: 8.250

7.  Myc Regulation of mRNA Cap Methylation.

Authors:  Victoria H Cowling; Michael D Cole
Journal:  Genes Cancer       Date:  2010-06

8.  Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells.

Authors:  Sianadh Dunn; Olivia Lombardi; Radoslaw Lukoszek; Victoria H Cowling
Journal:  Open Biol       Date:  2019-04-26       Impact factor: 6.411

Review 9.  MYC protein interactors in gene transcription and cancer.

Authors:  Diana Resetca; Cornelia Redel; Corey Lourenco; Peter Lin; Alannah S MacDonald; Roberto Ciaccio; Tristan M G Kenney; Yong Wei; David W Andrews; Maria Sunnerhagen; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2021-06-29       Impact factor: 60.716

10.  Quantitative DNA hypomethylation of ligand Jagged1 and receptor Notch1 signifies occurrence and progression of breast carcinoma.

Authors:  Yuwen Cao; Yixiao Li; Na Zhang; Jianming Hu; Liang Yin; Zemin Pan; Yucong Li; Xiaoming Du; Wenjie Zhang; Feng Li
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.